维普中文期刊产品整合服务
23篇 您的检索式:作者名="Ubezio"
    题名 作者 年代 出处 被引量
1The vascular targeting property of paclitaxel is enhanced by SU6668,a receptor tyrosine kinase inhibitor,causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
2The vascular targeting property of paclitaxel is enhanced by SU6668 ,a re- ceptor tyrosine kinase inhibitor, causing apoptosis of endothelial ceils and inhibition of angiogenesis 显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
3The vascular targeting property of paelitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis 显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
4The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
5The vascular targeting property of paclitaxel is enhanced by SU6668,a receptor tyrosine kinase inhibitor,causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
6A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer显示文摘Giuseppina Della Vittoria Scarpati Francesca Falcetta Chiara Carlomagno Paolo Ubezio Sergio Marchini Alfonso De Stefano Vijay Kumar Singh Maurizio D’Incalci Sabino De Placido Stefano Pepe 2012International Journal of Radiation Oncology, Biology, Physics2012,,:1
7The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A Borsotti P Cassis L Riccardi E 2006Clin Cancer Res2006,12,6:1
8The vascular targeting property of paclitaxel is enhanced by SU6668,a receptor tyrosine kinase inhibitor,causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
9The vascular targeting property of paclitaxel is enhanced by SU6668,a receptor tyrosine kinase inhibitor,causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
10Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes:ready-to-wear versus made-to-measure tool显示文摘Della Porta MG Ambaglio I Ubezio M 2012Hematologica2012,97,4:1
11Heterogeneous cell response to topotecan in a CFSE-based proliferation test显示文摘Matera G Lupi M Ubezio P 2004Cytometry A2004,62,2:1
12The vascular targeting property of paelitaxel is enhanced by SU6668, aredeptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibi- tion of angiogenesis 显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
13Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells 显示文摘UBEZIO P CIVOL1 F 1994Free Radic Biol Med1994,16,4:1
14The vascular targeting property of paclitaxel is enhanced by SU6668,a receptor tyrosine kinase inhibitor,causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
15The vascular targeting property of paelitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,:1
16The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis 显示文摘NAUMOVA E UBEZIO P GAROFALO A 2006Clin Cancer Res2006,12,6:1
17A generalised age- and phase-structured model of human tumour cell populations both unperturbed and exposed to a range of cancer therapies显示文摘Basse B Ubezio P 2007Bull Math Biol2007,69,5:1
18The vascular targeting property of paclitaxel is enhanced by SU6668,a redeptor tyrosine kinase inhibitor,causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
19The vascular targeting property of paclitaxel is enhanced by SU6668,a receptor lyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis显示文摘Naumova E Ubezio P Garofalo A 2006Clin Cancer Res2006,12,6:1
20Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancdr cells显示文摘UBEZIO P CIVOLI F 1994Free Radical Biol Med1994,16,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费